Quinine enhances photo-inactivation of pathogens

Leon G. Leanse

With the rise in antimicrobial resistance, it is becoming increasingly difficult to successfully treat infections caused by an array of pathogens1. Over the past few years, antimicrobial blue light (aBL) has been emerging as an novel ‘drug-free’ approach to tackle multidrug-resistant (MDR) infections.

免責事項: この要約は人工知能ツールを使用して翻訳されており、まだレビューまたは確認されていません